You have 8 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

non steroidal aromatase inhibitor (NSAI) exposure

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Breast Cancer Trial in Prato (Ribociclib, Aromatase Inhibitors, non steroideal, LHRH agonist)

Recruiting
  • Breast Cancer
  • Prato, Please Select:, Italy
    Hospital of Prato
Jul 27, 2022

Breast Cancer Trial (Gedatolisib, Palbociclib, Fulvestrant)

Not yet recruiting
  • Breast Cancer
  • (no location specified)
Aug 12, 2022

Breast Cancer Trial in Austria, Sweden (drug, biological, other)

Completed
Has Results
  • Breast Cancer
  • Placebo
  • +4 more
  • Baden, Austria
  • +46 more
Aug 5, 2022

HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer Trial in Canada (Endocrine therapy may include one of the following

Active, not recruiting
  • HR+ HER2- Men, Pre/Postmenopausal Advanced Breast Cancer
  • Endocrine therapy may include one of the following therapies: letrozole, anastrozole, exemestane, tamoxifen or fulvestrant
  • Endocrine therapy in combination with targeted therapy may include: everolimus plus exemestane or CDK4/6 inhibitor plus endocrine therapy
  • Calgary, Alberta, Canada
  • +24 more
Sep 12, 2022

Breast Tumor Female Trial in Netherlands (CDK 4/6 inhibitor, Non-Steroidal Aromatase Inhibitor, Fulvestrant)

Active, not recruiting
  • Breast Neoplasm Female
  • CDK 4/6 inhibitor
  • +2 more
  • Alkmaar, Netherlands
  • +71 more
Apr 1, 2022

Advanced Breast Cancer Trial in Spain (CB-103)

Active, not recruiting
  • Advanced Breast Cancer
  • Alzira, Spain
  • +14 more
Jun 7, 2022

Advanced Breast Cancer Trial in China (Everolimus, Exemestane, Everolimus Placebo)

Completed
  • Advanced Breast Cancer
  • Guangzhou, Guangdong, China
  • +14 more
Jun 17, 2022

Breast Cancer, Early-stage Breast Cancer, High Risk Breast Carcinoma Trial in United States (Abemaciclib, Tamoxifen,

Not yet recruiting
  • Breast Cancer
  • +2 more
  • Boston, Massachusetts
  • +7 more
Aug 14, 2023

Breast Cancer, Hormone Receptor Positive Tumor Trial in Germany (3 weeks Dose Induction of Everolimus, 3 weeks Conventional

Completed
  • Breast Cancer
  • Hormone Receptor Positive Tumor
  • 3 weeks Dose Induction of Everolimus
  • +3 more
  • Neu Isenburg, Hessen, Germany
  • +13 more
Feb 22, 2022

Renal Colic Trial (Piroxicam, Acetaminophen, Placebo)

Not yet recruiting
  • Renal Colic
  • (no location specified)
Feb 1, 2023

Breast Cancer Trial in Worldwide (Ribociclib, Letrozole or Anastrozole, Goserelin)

Active, not recruiting
  • Breast Cancer
  • Mobile, Alabama
  • +90 more
Dec 19, 2022

Breast Cancer Trial in Worldwide (Abemaciclib, Anastrozole, Letrozole)

Active, not recruiting
Has Results
  • Breast Cancer
  • Chandler, Arizona
  • +166 more
Jul 21, 2022

Renal Colic Trial in Monastir (Piroxicam, Placebo, paracetamol)

Recruiting
  • Renal Colic
  • Monastir, Tunisia
    Emergency Department of University Hospital of Monastir
Aug 16, 2022

Breast Cancer Female Trial in United Kingdom (Abemaciclib, Endocrine therapy)

Recruiting
  • Breast Cancer Female
  • Abemaciclib
  • Endocrine therapy (letrozole, anastrozole, exemestane or tamoxifen)
  • Truro, Cornwall, United Kingdom
  • +43 more
Jan 23, 2023

Breast Cancer, Breast Tumor Trial in San Francisco (Pazopanib)

Completed
Has Results
  • Breast Cancer
  • Breast Neoplasm
  • San Francisco, California
    University of California, San Francisco
Jul 7, 2020

Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer Trial in Singapore (Oral lenvatinib + Intravenous (IV)

Not yet recruiting
  • Hormone Receptor-Positive HER2-Negative Advanced Breast Cancer
  • Oral lenvatinib + Intravenous (IV) pembrolizumab + Oral letrozole
  • Singapore, Singapore
    National Cancer Centre Singapore
Oct 13, 2022

Ribociclib in Combination With Non-steroidal Aromatase

Completed
  • Breast Cancer
  • Sao Paulo, SP, Brazil
    Novartis Investigative Site
Nov 7, 2022

Aromatase Inhibitor Associated Musculoskeletal Symptoms (AIMSS)

Recruiting
  • Anatomic Stage 0 Breast Cancer AJCC v8
  • +4 more
  • Non-Interventional Study
  • Jacksonville, Florida
    Mayo Clinic in Florida
Oct 24, 2023

Ovarian Stimulation Trial in Shibin Al Kawm (Letrozole 2.5mg tablet)

Recruiting
  • Ovarian Stimulation
  • Letrozole 2.5mg tablet
  • Shibīn Al Kawm, Menoufia, Egypt
    Menoufia University hospital
Dec 8, 2021

Blood Vessel Function in Postmenopausal Women With Breast Cancer

Active, not recruiting
  • Breast Cancer
  • Rochester, Minnesota
    Mayo Clinic
Jan 17, 2023

CLEAR-B: Cancer Landscape - Early Adjuvant Retrospective

Recruiting
  • Breast Cancer
  • +2 more
    • Erlangen, Germany
      Department of Gynecology and Obstetrics, Erlangen University Hos
    May 12, 2023

    Examining the Effect of Endocrine Therapy on Aging

    Recruiting
    • Breast Neoplasm Female
    • +2 more
    • Aromatase inhibitor
    • Ann Arbor, Michigan
      University of Michigan Rogel Cancer Center
    Jan 17, 2023

    Breast Cancer Trial in Taichung (Diclofenac)

    Completed
    • Breast Cancer
    • Taichung, Taiwan
      China Medical University Hospital
    Jul 18, 2022

    2 Probiotic Solutions and 5 Classes of Drugs on Intestinal

    Not yet recruiting
    • Dysbiosis
    • Stool sampling
    • (no location specified)
    Oct 27, 2023

    Breast Cancer, Aromatase Inhibitors Trial in Montpellier, Nîmes (Whole-body cryotherapy, Placebo cryotherapy)

    Not yet recruiting
    • Breast Cancer
    • Aromatase Inhibitors
    • Whole-body cryotherapy
    • Placebo cryotherapy
    • Montpellier, France
    • +1 more
    Jul 28, 2022